title: Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.
abstract: Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or single nucleotide polymorphisms (SNPs) in 279 participants from a clinical trial of adjuvant imatinib mesylate. Given previous evidence that certain susceptibility loci and carcinogens are associated with characteristic mutations, or "signatures" in other cancers, we hypothesized that the characteristic somatic mutations in the KIT and PDGFRA genes in GIST tumors may similarly be mutational signatures that are causally linked to specific mutagens or susceptibility loci. As previous epidemiologic studies suggest environmental risk factors such as dioxin and radiation exposure may be linked to sarcomas, we chose 208 variants in 39 candidate genes related to DNA repair and dioxin metabolism or response. We calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each variant and 7 categories of tumor mutation using logistic regression. We also evaluated gene-level effects using the sequence kernel association test (SKAT). Although none of the association p-values were statistically significant after adjustment for multiple comparisons, SNPs in CYP1B1 were strongly associated with KIT exon 11 codon 557-8 deletions (OR = 1.9, 95% CI: 1.3-2.9 for rs2855658 and OR = 1.8, 95% CI: 1.2-2.7 for rs1056836) and wild type GISTs (OR = 2.7, 95% CI: 1.5-4.8 for rs1800440 and OR = 0.5, 95% CI: 0.3-0.9 for rs1056836). CYP1B1 was also associated with these mutations categories in the SKAT analysis (p = 0.002 and p = 0.003, respectively). Other potential risk variants included GSTM1, RAD23B and ERCC2. This preliminary analysis of inherited genetic risk factors for GIST offers some clues about the disease's genetic origins and provides a starting point for future candidate gene or gene-environment research.
authors: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors: Katie M
authors: KM
authors: O'Brien
authors: Irene
authors: I
authors: Orlow
authors: Cristina R
authors: CR
authors: Antonescu
authors: Karla
authors: K
authors: Ballman
authors: Linda
authors: L
authors: McCall
authors: Ronald
authors: R
authors: DeMatteo
authors: Lawrence S
authors: LS
authors: Engel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D001549:Benzamides / Q000627:therapeutic use; D065633:Cytochrome P-450 CYP1B1; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000235:genetics*; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use; D020641:Polymorphism, Single Nucleotide; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*; D011743:Pyrimidines / Q000627:therapeutic use; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D012307:Risk Factors
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D001189:Aryl Hydrocarbon Hydroxylases; C585496:CYP1B1 protein, human; D065633:Cytochrome P-450 CYP1B1; D019009:Proto-Oncogene Proteins c-kit; D020796:Receptor, Platelet-Derived Growth Factor alpha
references: Hum Pathol. 2001 Jun;32(6):578-82
references: 11431711
references: Am J Epidemiol. 2006 Aug 15;164(4):297-302
references: 16707649
references: APMIS. 2006 Mar;114(3):192-200
references: 16643186
references: Am J Epidemiol. 1997 Jun 15;145(12):1061-75
references: 9199536
references: Cancer Epidemiol. 2009 Oct;33(3-4):276-80
references: 19736056
references: Annu Rev Pathol. 2008;3:557-86
references: 18039140
references: Science. 1998 Jan 23;279(5350):577-80
references: 9438854
references: J Hum Genet. 2003;48(12):654-658
references: 14634838
references: Mol Biol Rep. 2012 Mar;39(3):2821-9
references: 21674184
references: Eur J Cancer. 2010 Jun;46(9):1617-31
references: 20207535
references: Acta Oncol. 2008;47(3):347-54
references: 18347998
references: Mutat Res. 2000 Nov 30;456(1-2):39-44
references: 11087894
references: Clin Cancer Res. 2011 Nov 15;17(22):6973-84
references: 21908578
references: Semin Cancer Biol. 2004 Dec;14(6):441-8
references: 15489137
references: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
references: 18326623
references: Mutat Res. 2005 Jun 3;573(1-2):70-82
references: 15829238
references: Asian Pac J Cancer Prev. 2011;12(12):3357-60
references: 22471480
references: Cancer. 2008 Feb 1;112(3):608-15
references: 18076015
references: J Am Coll Surg. 2009 Jul;209(1):7-16
references: 19651058
references: Histol Histopathol. 2008 Nov;23(11):1379-86
references: 18785120
references: Pharmacogenet Genomics. 2010 Aug;20(8):507-15
references: 20577141
references: Cancer Res. 2004 Sep 1;64(17):5913-9
references: 15342366
references: J Pathol. 2008 Sep;216(1):64-74
references: 18623623
references: Metabolism. 2012 Sep;61(9):1321-9
references: 22459615
references: Neoplasma. 2010;57(1):15-9
references: 19895167
references: Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1647-53
references: 16985026
references: Cancer Epidemiol. 2010 Jun;34(3):328-37
references: 20381444
references: World J Gastroenterol. 2010 Sep 7;16(33):4227-32
references: 20806443
references: Lung Cancer. 2010 Dec;70(3):247-52
references: 20395011
references: Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):536-42
references: 16537713
references: J Toxicol Environ Health A. 2008;71(13-14):887-97
references: 18569591
references: J Clin Oncol. 2005 Aug 10;23(23):5357-64
references: 15928335
references: Int J Cancer. 2005 Feb 20;113(5):761-8
references: 15499621
references: Cancer Causes Control. 2012 May;23(5):671-81
references: 22418777
references: Br J Cancer. 2010 Jul 13;103(2):165-70
references: 20588273
references: Virchows Arch. 2001 Jan;438(1):1-12
references: 11213830
references: Carcinogenesis. 2005 Mar;26(3):597-604
references: 15564288
references: Neoplasma. 2011;58(4):352-9
references: 21520994
references: Behav Brain Res. 2001 Nov 1;125(1-2):279-84
references: 11682119
references: Carcinogenesis. 2009 May;30(5):785-92
references: 19270000
references: Gastroenterology. 2002 May;122(5):1493-9
references: 11984533
references: Stem Cells. 2009 Mar;27(3):489-97
references: 19074414
references: Clin Cancer Res. 2003 Aug 15;9(9):3329-37
references: 12960119
references: Am J Surg Pathol. 2008 Oct;32(10):1560-5
references: 18724244
references: Am J Epidemiol. 2011 Apr 15;173(8):847-57
references: 21436184
references: Environ Mol Mutagen. 2001;38(2-3):223-6
references: 11746758
references: J Natl Cancer Inst. 2011 Mar 2;103(5):425-35
references: 21263130
references: J Epidemiol. 2000 Sep;10(5):349-60
references: 11059519
references: Clin Cancer Res. 2012 Aug 15;18(16):4458-64
references: 22718859
references: Tumour Biol. 2012 Jun;33(3):809-16
references: 22190224
references: IARC Sci Publ. 2004;(157):247-70
references: 15055300
references: Mol Biol Rep. 2012 Jul;39(7):7465-71
references: 22327650
references: Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(1):40-53
references: 20075607
references: J Clin Oncol. 2004 Oct 1;22(19):3997-4001
references: 15459223
references: Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
references: 17090188
references: Lancet. 2009 Mar 28;373(9669):1097-104
references: 19303137
references: Clin Cancer Res. 2005 Jun 1;11(11):4182-90
references: 15930355
references: Int J Cancer. 2006 Oct 1;119(7):1732-5
references: 16646069
references: Scand J Work Environ Health. 2003 Jun;29(3):220-9
references: 12828392
references: Carcinogenesis. 2004 Apr;25(4):559-65
references: 14656940
references: J Am Coll Surg. 2006 Apr;202(4):623-9
references: 16571433
references: Photochem Photobiol. 2009 Jan-Feb;85(1):379-86
references: 19161404
references: Arch Surg. 1992 Dec;127(12):1379-85
references: 1365680
references: Mutat Res. 2008 Mar 1;639(1-2):11-9
references: 18067928
references: Am J Epidemiol. 2002 Jul 15;156(2):95-109
references: 12117698
references: Med Oncol. 2012 Dec;29(5):3039-45
references: 22815156
references: Am J Hum Genet. 2011 Jul 15;89(1):82-93
references: 21737059
references: Hum Pathol. 2008 Dec;39(12):1728-36
references: 18715619
references: Am J Hum Genet. 2010 Jun 11;86(6):929-42
references: 20560208
references: Am J Surg Pathol. 2005 Jan;29(1):52-68
references: 15613856
references: Am J Gastroenterol. 2005 Jan;100(1):162-8
references: 15654796
references: Ann Oncol. 2012 Feb;23(2):353-60
references: 21527588
references: Lancet. 2007 May 19;369(9574):1731-41
references: 17512858
references: Biostatistics. 2003 Jan;4(1):57-74
references: 12925330